INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
50 hedge funds and large institutions have $337M invested in Inozyme Pharma in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
50
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.46M | |
| 2 | +$3.66M | |
| 3 | +$3.39M | |
| 4 |
O
OrbiMed
New York
|
+$3.22M |
| 5 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
+$1.24M |
Top Sellers
| 1 | -$3.52M | |
| 2 | -$1.73M | |
| 3 | -$1.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.18M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$338K |